Notice of Meeting, 22849-22850 [2019-10452]

Download as PDF khammond on DSKBBV9HB2PROD with NOTICES Federal Register / Vol. 84, No. 97 / Monday, May 20, 2019 / Notices public comments about the impact and use of Evidence-based Practice Center (EPC) Program evidence reviews. Members of the public include health care delivery organizations, guideline developers, payers, quality measure developers, research funders, and other organizations, including patient organizations, that have used AHRQ EPC evidence reviews. DATES: Comments must be received by xxxx, 2019. ADDRESSES: Send responses to epc@ ahrq.hhs.gov. FOR FURTHER INFORMATION CONTACT: The AHRQ EPC Program at epc@ ahrq.hhs.gov. SUPPLEMENTARY INFORMATION: Established in 1997, the mission of the EPC Program (https:// effectivehealthcare.ahrq.gov/about/epc) is to create evidence reviews that improve health care by supporting evidence-based decision making by patients, providers, and policymakers. Evidence reviews summarize and synthesize existing literature and evidence using rigorous methods. Understanding that knowledge synthesis is, by itself, insufficient to change health care practice and improve patient outcomes, the EPC Program has relied on partners who are committed to using these reports. Over the 20 years of its existence, the EPC Program has partnered with clinical professional organizations, federal agencies, and other health care organizations. These organizations have used EPC evidence reviews for a variety of activities, including developing clinical practice guidelines, coverage decisions, program planning, funding opportunities and more. The EPC Program is committed to innovation and improving the utility of its evidence reviews. AHRQ wants to hear specific details about how organizations and people have used the information from EPC evidence reviews. This is especially important since 2019 is the last fiscal year in which funds appropriated to the Patient-Centered Outcomes Research Trust Fund, which has funded many EPC evidence reviews, will be made available to HHS. Therefore, the EPC Program wants to understand the impact of the AHRQ EPC evidence reviews and the effectiveness of its partnerships. AHRQ seeks feedback: • From clinical professional societies or other groups who used AHRQ EPC evidence reviews for developing guidelines • From payers who used an AHRQ EPC evidence review to make coverage or other decisions VerDate Sep<11>2014 16:41 May 17, 2019 Jkt 247001 • From health systems who used an AHRQ EPC evidence review to change how health care is practiced or delivered • From research funders who used an AHRQ EPC evidence review to set a research agenda • From other organizations including patient organizations that have used AHRQ EPC evidence reviews for various purposes Specific questions of interest to AHRQ include, but are not limited to: • How you heard about the AHRQ EPC review • How you used the AHRQ EPC evidence review • How the AHRQ EPC evidence review changed your decision, recommendation, or action • What you would have done in the absence of an EPC report • Was the AHRQ EPC evidence review acknowledged or referenced in your decision, recommendation, or action? If so, how? And if not, why not? • Your assessment of the value of the unique contribution provided by AHRQ in conducting evidence reviews for improving patient care and outcomes • Based on your experiences, suggestions for how the EPC program can make its evidence reviews more useful and impactful AHRQ is interested in all of the questions listed above, but respondents are welcome to address as many or as few as they choose and to address additional areas of interest not listed. This RFI is for planning purposes only and should not be construed as a policy, solicitation for applications, or as an obligation on the part of the Government to provide support for any ideas in response to it. AHRQ will use the information submitted in response to this RFI at its discretion, and will not provide comments to any respondent’s submission. However, responses to the RFI may be reflected in future solicitation(s) or policies. Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received or provide feedback to respondents with respect to any information submitted. No proprietary, classified, confidential or sensitive information should be included in your response. The Government reserves the right to use any non-proprietary technical information in any resultant solicitation(s). The contents of all submissions will be made available to the public upon request. Submitted PO 00000 Frm 00044 Fmt 4703 Sfmt 4703 22849 materials must be publicly available or able to be made public. Gopal Khanna, Director. [FR Doc. 2019–10451 Filed 5–17–19; 8:45 am] BILLING CODE 4160–90–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Agency for Healthcare Research and Quality Notice of Meeting Agency for Healthcare Research and Quality, HHS. ACTION: Notice. AGENCY: The Agency for Healthcare Research and Quality (AHRQ) is announcing a Special Emphasis Panel (SEP) meeting on AHRQ–HS–19–001, ‘‘Patient Safety Learning Laboratories (2019): Pursuing Safety in Diagnosis and Treatment at the Intersection of Design, Systems Engineering, and Health Services Research (R18).’’ DATES: June 12, 2019 (Open on June 12th from 8:00 a.m. to 8:15 a.m. and closed for the remainder of the meeting). ADDRESSES: Bethesda Marriott Hotel, 5151 Pooks Hill Rd., Bethesda, MD 20852. FOR FURTHER INFORMATION CONTACT: Anyone wishing to obtain a roster of members, agenda or minutes of the nonconfidential portions of this meeting should contact: Heather Phelps, Acting Committee Management Officer, Office of Extramural Research, Education and Priority Populations, AHRQ, 5600 Fishers Lane, Rockville, Maryland 20850, Telephone: (301) 427–1128. Agenda items for this meeting are subject to change as priorities dictate. SUPPLEMENTARY INFORMATION: A Special Emphasis Panel is a group of experts in fields related to health care research who are invited by AHRQ, and agree to be available, to conduct on an as needed basis, scientific reviews of applications for AHRQ support. Individual members of the SEP do not attend regularlyscheduled meetings and do not serve for fixed terms or a long period of time. Rather, they are asked to participate in particular review meetings which require their type of expertise. In accordance with section 10(a)(2) of the Federal Advisory Committee Act (5 U.S.C. App. 2), announcement is made of an AHRQ SEP meeting on AHRQ– HS–19–001, ‘‘Patient Safety Learning Laboratories (2019): Pursuing Safety in Diagnosis and Treatment at the Intersection of Design, Systems SUMMARY: E:\FR\FM\20MYN1.SGM 20MYN1 22850 Federal Register / Vol. 84, No. 97 / Monday, May 20, 2019 / Notices Engineering, and Health Services Research (R18).’’ Each SEP meeting will commence in open session before closing to the public for the duration of the meeting. The SEP meeting referenced above will be closed to the public in accordance with the provisions set forth in 5 U.S.C. App. 2, section 10(d), 5 U.S.C. 552b(c)(4), and 5 U.S.C. 552b(c)(6). Grant applications for the AHRQ–HS–19–001, ‘‘Patient Safety Learning Laboratories (2019): Pursuing Safety in Diagnosis and Treatment at the Intersection of Design, Systems Engineering, and Health Services Research (R18)’’ are to be reviewed and discussed at this meeting. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Gopal Khanna, Director. [FR Doc. 2019–10452 Filed 5–17–19; 8:45 am] BILLING CODE 4160–90–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Medicare & Medicaid Services [Document Identifier: CMS–10455 and CMS– 10379] Agency Information Collection Activities: Submission for OMB Review; Comment Request Centers for Medicare & Medicaid Services, HHS. ACTION: Notice. AGENCY: The Centers for Medicare & Medicaid Services (CMS) is announcing an opportunity for the public to comment on CMS’ intention to collect information from the public. Under the Paperwork Reduction Act of 1995 (PRA), federal agencies are required to publish notice in the Federal Register concerning each proposed collection of information, including each proposed extension or reinstatement of an existing collection of information, and to allow a second opportunity for public comment on the notice. Interested persons are invited to send comments regarding the burden estimate or any other aspect of this collection of information, including the necessity and utility of the proposed information collection for the proper performance of khammond on DSKBBV9HB2PROD with NOTICES SUMMARY: VerDate Sep<11>2014 16:41 May 17, 2019 Jkt 247001 1. Type of Information Collection Request: Revision of a currently approved collection; Title of Information Collection: Report of a Hospital Death Associated with Restraint or Seclusion; Use: The final rule, which finalized the regulations at 42 CFR 482.13(g), published on May, 16, 2012 (77 FR 29074) included a DATES: Comments on the collection(s) of reduction in the reporting requirements information must be received by the related to hospital deaths associated OMB desk officer by June 19, 2019. with the use of restraint or seclusion. ADDRESSES: When commenting on the Section § 482.13(g) requires that proposed information collections, hospitals must use form CMS–10455 to please reference the document identifier report those deaths associated with or OMB control number. To be assured restraint and/or seclusion directly to the consideration, comments and Centers for Medicare & Medicaid recommendations must be received by Services (CMS) Regional Office (RO). In the OMB desk officer via one of the addition, the final rule replaced the following transmissions: OMB, Office of previous requirement for reporting via Information and Regulatory Affairs, telephone to CMS, which proved to be Attention: CMS Desk Officer, Fax cumbersome for both CMS and Number: (202) 395–5806 OR Email: hospitals, with a requirement that OIRA_ submission@omb.eop.gov. allows the submission of reports on the To obtain copies of a supporting form CMS–10455 via facsimile or statement and any related forms for the electronically, as determined by CMS. proposed collection(s) summarized in This reporting requirement applies to this notice, you may make your request hospitals, Critical Access Hospitals using one of following: (CAHs) and rehabilitation or psychiatric 1. Access CMS’ website address at distinct part units (DPUs) in hospitals website address at https://www.cms.gov/ and CAHs. Currently, the hospital, CAH, Regulations-and-Guidance/Legislation/ or rehabilitation or psychiatric DPU PaperworkReductionActof1995/PRAmust submit the form CMS–10455 to the Listing.html. CMS RO via fax or email, based on RO’s 1. Email your request, including your preference. Beginning on May 9, 2014, address, phone number, OMB number, hospitals were no longer required to and CMS document identifier, to report to CMS, those deaths that were Paperwork@cms.hhs.gov. not associated with the use of seclusion 2. Call the Reports Clearance Office at and where the only restraints used were (410) 786–1326. 2-point soft wrist restraints. This FOR FURTHER INFORMATION CONTACT: reporting requirement change resulted William Parham at (410) 786–4669. in no necessary edits to the form CMS– 10455. However, despite the change in SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995 (PRA) reporting requirements, hospitals and CAHs continued to submit unnecessary (44 U.S.C. 3501–3520), federal agencies CMS–10455 forms when there was only must obtain approval from the Office of Management and Budget (OMB) for each use of 2-point soft wrist restraints without the use of seclusion. Therefore, collection of information they conduct form CMS–10455 was modified in July or sponsor. The term ‘‘collection of 2018 to include instructions stating that information’’ is defined in 44 U.S.C. the submission of this form is not 3502(3) and 5 CFR 1320.3(c) and required for deaths associated with the includes agency requests or requirements that members of the public use of only 2-point soft wrist restraints submit reports, keep records, or provide without seclusion. It was estimated that this change would reduce the volume of information to a third party. Section reports to be submitted by 90 percent for 3506(c)(2)(A) of the PRA (44 U.S.C. hospitals. 3506(c)(2)(A)) requires federal agencies In this information collection request, to publish a 30-day notice in the CMS is seeking OMB approval for an Federal Register concerning each electronically submitted version of the proposed collection of information, currently approved paper version of including each proposed extension or form CMS–10455. Form Number: CMS– reinstatement of an existing collection 10455 (OMB control number: 0938– of information, before submitting the 1210); Frequency: Occasionally; collection to OMB for approval. To Affected Public: Private Sector; Number comply with this requirement, CMS is of Respondents: 6,389; Number of publishing this notice that summarizes Responses: 6,389; Total Annual Hours: the following proposed collection(s) of 6,389. (For policy questions regarding information for public comment: the agency’s functions, the accuracy of the estimated burden, ways to enhance the quality, utility, and clarity of the information to be collected, and the use of automated collection techniques or other forms of information technology to minimize the information collection burden. PO 00000 Frm 00045 Fmt 4703 Sfmt 4703 E:\FR\FM\20MYN1.SGM 20MYN1

Agencies

[Federal Register Volume 84, Number 97 (Monday, May 20, 2019)]
[Notices]
[Pages 22849-22850]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-10452]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Agency for Healthcare Research and Quality


Notice of Meeting

AGENCY: Agency for Healthcare Research and Quality, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Agency for Healthcare Research and Quality (AHRQ) is 
announcing a Special Emphasis Panel (SEP) meeting on AHRQ-HS-19-001, 
``Patient Safety Learning Laboratories (2019): Pursuing Safety in 
Diagnosis and Treatment at the Intersection of Design, Systems 
Engineering, and Health Services Research (R18).''

DATES: June 12, 2019 (Open on June 12th from 8:00 a.m. to 8:15 a.m. and 
closed for the remainder of the meeting).

ADDRESSES: Bethesda Marriott Hotel, 5151 Pooks Hill Rd., Bethesda, MD 
20852.

FOR FURTHER INFORMATION CONTACT: Anyone wishing to obtain a roster of 
members, agenda or minutes of the non-confidential portions of this 
meeting should contact: Heather Phelps, Acting Committee Management 
Officer, Office of Extramural Research, Education and Priority 
Populations, AHRQ, 5600 Fishers Lane, Rockville, Maryland 20850, 
Telephone: (301) 427-1128.
    Agenda items for this meeting are subject to change as priorities 
dictate.

SUPPLEMENTARY INFORMATION: A Special Emphasis Panel is a group of 
experts in fields related to health care research who are invited by 
AHRQ, and agree to be available, to conduct on an as needed basis, 
scientific reviews of applications for AHRQ support. Individual members 
of the SEP do not attend regularly-scheduled meetings and do not serve 
for fixed terms or a long period of time. Rather, they are asked to 
participate in particular review meetings which require their type of 
expertise.
    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (5 U.S.C. App. 2), announcement is made of an AHRQ SEP 
meeting on AHRQ-HS-19-001, ``Patient Safety Learning Laboratories 
(2019): Pursuing Safety in Diagnosis and Treatment at the Intersection 
of Design, Systems

[[Page 22850]]

Engineering, and Health Services Research (R18).''
    Each SEP meeting will commence in open session before closing to 
the public for the duration of the meeting. The SEP meeting referenced 
above will be closed to the public in accordance with the provisions 
set forth in 5 U.S.C. App. 2, section 10(d), 5 U.S.C. 552b(c)(4), and 5 
U.S.C. 552b(c)(6). Grant applications for the AHRQ-HS-19-001, ``Patient 
Safety Learning Laboratories (2019): Pursuing Safety in Diagnosis and 
Treatment at the Intersection of Design, Systems Engineering, and 
Health Services Research (R18)'' are to be reviewed and discussed at 
this meeting. The grant applications and the discussions could disclose 
confidential trade secrets or commercial property such as patentable 
material, and personal information concerning individuals associated 
with the grant applications, the disclosure of which would constitute a 
clearly unwarranted invasion of personal privacy.

Gopal Khanna,
Director.
[FR Doc. 2019-10452 Filed 5-17-19; 8:45 am]
BILLING CODE 4160-90-P